Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-29 @ 12:27 PM
Study NCT ID:
NCT00716092
Status:
COMPLETED
Last Update Posted:
2014-06-27
First Post:
2008-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-07-15
First Submit QC Date:
None
Study First Post Date:
2008-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-13
Results First Submit QC Date:
None
Results First Post Date:
2011-06-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-18
Last Update Post Date:
2014-06-27
Last Update Post Date Type:
ESTIMATED